ShareValue scores for 300485.SHE: Valuation 48, Quality 43, Growth 32, Health 57.

300485.SHE
SZSE

Beijing Science Sun Pharmaceutical Co Ltd

CN¥9.63(+5.94%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 16%
Valuation
48
Fair Value
Price vs Value
Quality
43
Moderate
Business Strength
Growth
32
Weak
Revenue & Earnings
Health
57
Moderate
Financial Stability
Momentum
34
Bearish
Price Trend

Company Details

About

Beijing Science Sun Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of injections in China. The company offers products for cardiovascular, cerebrovascular, immunomodulation, and nervous systems, and other drugs. It is also involved in raw materials, solid oral preparations, and health products; extraction of traditional Chinese medicine; manufacture of Chinese and Western medicine preparations; research, development, production, and sales of tablets, hard capsules, powders, granules, and active pharmaceutical ingredients; outward investment, technology introduction and exchange, international business development, livestock and poultry production, and research and development of bio-organic fertilizers and bio-feeds. In addition, the company is engaged venture capital; equity investment through private equity funds; technology development, transfer, and services for biological products, pharmaceuticals, diagnostic reagents, and medical devices; biotechnology information consulting; sales of immunoassay reagents and laboratory instruments; research, development and industrialization of human vaccines; investment management and consulting for non-securities businesses, as well as inspection and testing services, consulting services, and health food production. The company was founded in 1999 and is headquartered in Beijing, China. Address: No.8, Xingsheng Street, Beijing, China, 100176

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026